Free Trial

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$3.99 -0.01 (-0.25%)
(As of 12/20/2024 05:15 PM ET)

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/20/2024
10:56 AM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM
Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM
Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
8:34 AM
Biodexa Pharmaceuticals (Filer)
Form 424B5
07/19/2024
12:00 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K/A
07/19/2024
8:03 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:46 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/05/2024
4:24 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:44 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:46 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/17/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2024
8:48 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
8:04 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/28/2024
4:03 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
9:10 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:14 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:16 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
9:21 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/22/2024
8:23 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:53 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
5:46 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/02/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
04/30/2024
12:11 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
8:47 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

04/29/2024
8:49 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/29/2024
8:55 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/26/2024
7:45 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:19 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:24 PM
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
03/28/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
03/18/2024
3:31 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/28/2024
3:14 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BDRX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners